Multiple sclerosis is often diagnosed in patients who are planning on having children.
Although multiple sclerosis does not negatively influence most pregnancy outcomes, less is …

Inflammatory bowel disease (IBD) has a peak age of diagnosis before the age of 35 years.
Concerns about infertility, adverse pregnancy outcomes, and heritability of IBD have …

Objective To report pregnancy outcomes and disease activity (DA) in women with MS,
neuromyelitis optica spectrum disorders (NMOSDs), and other neuroimmunologic diseases …

Objective: The objective of this study was to develop evidence-based recommendations on
pregnancy management for persons with multiple sclerosis (MS). Background: MS typically …

Introduction: Pregnancy is widely accepted as a period when relapses of multiple sclerosis
(MS) are decreased, with an increased risk of relapse in the first months postpartum. This …

Multiple sclerosis (MS) is an autoimmune-mediated degenerative disease of the central
nervous system, characterized by inflammatory demyelination. It is primarily found in women …

The aim of this study was to investigate the effects of cladribine use, in the last 6 months
prior (56.4%) to or after (43.6%) the last menstrual period in a population of women with …

Objective Assessing the risk of clinical and radiological reactivation during pregnancy and
post partum in women with multiple sclerosis (MS) treated with natalizumab (NTZ) …

Objective To summarize the available literature and provide an overview of in utero
exposure to maternal multiple sclerosis (MS) and the influence on offspring health …

Background Most disease-modifying therapies (DMTs) approved for the treatment of multiple
sclerosis (MS) are not recommended during pregnancy, and discouraged while …